Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Storb, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 343 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buckner, CD; Epstein, RB; Rudolph, RH; Clift, RA; Storb, R; Thomas, ED
      Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia (Reprinted from Blood, vol 35, pg 741-750, 1970)

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Maris, M; Sandmaier, BM; Maloney, DG; McSweeney, PA; Woolfrey, A; Chauncey, T; Shizuru, J; Niederwieser, D; Blume, KG; Forman, S; Storb, R
      Non-myeloablative hematopoietic stem cell transplantation

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    3. Maris, M; Woolfrey, A; McSweeney, PA; Sandmaier, BM; Nash, RA; Georges, G; Maloney, DG; Molina, A; Chauncey, T; Yu, C; Zaucha, JM; Blume, KG; Shizuru, J; Niederwieser, D; Storb, R
      Nonmyeloablative hematopoietic stem cell transplantation: Transplantation for the 21(st) century

      FRONTIERS IN BIOSCIENCE
    4. Zaucha, JM; Yu, C; Zellmer, E; Takatu, A; Junghanss, C; Little, MT; Storb, R
      Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral bloodmononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    5. Wagner, JL; Flowers, MED; Longton, G; Storb, R; Martin, P
      Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    6. Bruno, B; Gooley, T; Sullivan, KM; Davis, C; Bensinger, WI; Storb, R; Nash, RA
      Secondary failure of platelet recovery after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    7. Anderson, JE; Appelbaum, FR; Schoch, G; Barnett, T; Chauncey, TR; Flowers, MED; Storb, R
      Relapse alter allogeneic bone marrow transplantation for refractory anemiais increased by shielding lungs and liver during total body irradiation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    8. Zaucha, JM; Zellmer, E; Georges, G; Little, MT; Storb, R; Storer, B; Torok-Storb, B
      G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    9. Bruno, B; Goerner, M; Nash, RA; Storb, R; Kiem, HP; McSweeney, PA
      Purified canine CD34(+)Lin(-) marrow cells transduced with retroviral vectors give rise to long-term multi-lineage hematopoiesis

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    10. Zaucha, JM; Yu, C; Lothrop, CD; Nash, RA; Sale, G; Georges, G; Kiem, HP; Niemeyer, GP; Dufresne, M; Cao, QF; Storb, R
      Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    11. Storb, R; Blume, KG; O'Donnell, MR; Chauncey, T; Forman, SJ; Deeg, HJ; Hu, WW; Appelbaum, FR; Doney, K; Flowers, MED; Sanders, J; Leisenring, W
      Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    12. Storb, R
      In memoriam: George Wesley Santos

      CURRENT OPINION IN HEMATOLOGY
    13. Feinstein, L; Storb, R
      Reducing transplant toxicity

      CURRENT OPINION IN HEMATOLOGY
    14. Feinstein, L; Storb, R
      Nonmyeloablative hematopoietic cell transplantation

      CURRENT OPINION IN ONCOLOGY
    15. Storb, R
      Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?

      LEUKEMIA
    16. Witherspoon, RP; Deeg, HJ; Storer, B; Anasetti, C; Storb, R; Appelbaum, FR
      Hematopoietic stern-cell transplantation for treatment-related leukemia ormyelodysplasia

      JOURNAL OF CLINICAL ONCOLOGY
    17. Bensinger, WI; Maloney, D; Storb, R
      Allogeneic hematopoietic cell transplantation for multiple myeloma

      SEMINARS IN HEMATOLOGY
    18. Bensinger, WI; Martin, PJ; Storer, B; Clift, R; Forman, SJ; Negrin, R; Kashyap, A; Flowers, MED; Lilleby, K; Chauncey, TR; Storb, R; Rowley, S; Heimfeld, S; Blume, K
      Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

      NEW ENGLAND JOURNAL OF MEDICINE
    19. Al-Ghamdi, H; Leisenring, W; Bensinger, WI; Nash, RA; Storb, R; Appelbaum, FR; Martin, PJ
      A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest

      BRITISH JOURNAL OF HAEMATOLOGY
    20. Jurado, M; Deeg, HJ; Gooley, T; Anasetti, C; Chauncey, T; Flowers, MED; Myerson, D; Storb, R; Appelbaum, FR
      Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    21. Goerner, M; Horn, PA; Peterson, L; Kurre, P; Storb, R; Rasko, JEJ; Kiem, HP
      Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors

      BLOOD
    22. Ulrich, CM; Storb, R; Schubert, MM; Potter, D
      MTHFR polymorphism, DNA repair capacity, and methotrexate toxicity

      BLOOD
    23. Torok-Storb, B; Bolles, L; Iwata, M; Doney, K; Sale, GE; Gooley, TA; Storb, R
      Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia

      BLOOD
    24. Zaucha, JM; Yu, C; Mathioudakis, G; Seidel, K; Georges, G; Sale, G; Little, MT; Torok-Storb, B; Storb, R
      Hematopoietic responses to stress conditions in young dogs compared with elderly dogs

      BLOOD
    25. Storek, J; Joseph, A; Espino, G; Dawson, MA; Douek, DC; Sullivan, KM; Flowers, MED; Martin, P; Mathioudakis, G; Nash, RA; Storb, R; Appelbaum, FR; Maloney, DG
      Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation

      BLOOD
    26. Weissinger, F; Sandmaier, BM; Maloney, DG; Bensinger, WI; Gooley, T; Storb, R
      Decreased transfusion requirements for patients receiving nonmyeloablativecompared with conventional peripheral blood stem cell transplants from HLA-identical siblings

      BLOOD
    27. Kansu, E; Gooley, T; Flowers, MED; Anasetti, C; Deeg, HJ; Nash, RA; Sanders, JE; Witherspoon, RP; Appelbaum, FR; Storb, R; Martin, PJ
      Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial

      BLOOD
    28. Zaucha, JM; Gooley, T; Bensinger, WI; Heimfeld, S; Chauncey, TR; Zaucha, R; Martin, PJ; Flowers, MED; Storek, J; Georges, G; Storb, R; Torok-Storb, B
      CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation

      BLOOD
    29. Georges, GE; Storb, R; Bruno, B; Brodie, SJ; Thompson, JD; Taranova, AG; Zaucha, JM; Little, MT; Zellmer, E; Moore, PF; Gooley, T; Sale, G; Kiem, HP; Sandmaier, BM; Lyons, RM; Nash, RA
      Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes

      BLOOD
    30. Ulrich, CM; Yasui, Y; Storb, R; Schubert, MM; Wagner, JL; Bigler, J; Ariail, KS; Keener, CL; Li, S; Liu, H; Farin, FM; Potter, JD
      Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

      BLOOD
    31. Storb, R; Sale, G; Barnett, T; Yu, C; Zellmer, E; Little, MT
      Transient mixed hematopoietic chimerism in dogs given thymic irradiation before and pharmacologic immunosuppression after marrow transplantation

      BLOOD
    32. Storek, J; Dawson, MA; Storer, B; Stevens-Ayers, T; Maloney, DG; Marr, KA; Witherspoon, RP; Bensinger, W; Flowers, MED; Martin, P; Storb, R; Appelbaum, FR; Boeckh, M
      Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

      BLOOD
    33. Witherspoon, RP; Deeg, HJ; Storb, R; Appelbaum, FR; Hutchinson, F
      Secondary leukemia or myelodysplasia treated by bone marrow transplantation

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    34. Carnevale-Schianca, F; Martin, P; Sullivan, K; Flowers, M; Gooley, T; Anasetti, C; Deeg, J; Furlong, T; McSweeney, P; Storb, R; Nash, RA
      Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    35. Wagner, JL; Seidel, K; Boeckh, M; Storb, R
      De novo chronic graft-veusus-host disease in marrow graft recipients givenmethotrexate and cyclosporine: Risk factors and survival

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    36. Flowers, MED; Leisenring, W; Beach, K; Riddell, S; Radich, JP; Higano, CS; Rowley, SD; Chauncey, TR; Bensinger, WI; Sanders, JE; Anasetti, C; Storb, R; Wade, J; Appelbaum, FR; Martin, PJ
      Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    37. Furlong, T; Storb, R; Anasetti, C; Appelbaum, FR; Deeg, HJ; Doney, K; Martin, P; Sullivan, K; Witherspoon, R; Nash, RA
      Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acutegraft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

      BONE MARROW TRANSPLANTATION
    38. Sierra, J; Storer, B; Hansen, JA; Martin, PJ; Petersdorf, EW; Woolfrey, A; Matthews, D; Sanders, JE; Storb, R; Appelbaum, FR; Anasetti, C
      Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience

      BONE MARROW TRANSPLANTATION
    39. Carella, AM; Champlin, R; Slavin, S; McSweeney, P; Storb, R
      Mini-allografts: ongoing trials in humans

      BONE MARROW TRANSPLANTATION
    40. Cavallaro, AM; Lilleby, K; Majolino, I; Storb, R; Appelbaum, FR; Rowley, SD; Bensinger, WI
      Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

      BONE MARROW TRANSPLANTATION
    41. Witherspoon, RP; Deeg, HJ; Fisher, LV; Schoch, G; Storb, R
      Secondary malignancies after allogeneic or autologous marrow transplantation

      SECONDARY NEOPLASIAS FOLLOWING CHEMOTHERAPY, RADIOTHERAPY, AND IMMUNOSUPPRESSION
    42. Storek, J; Storb, R
      T-cell reconstitution after stem-cell transplantation - by which organ?

      LANCET
    43. Sandmaier, BM; McSweeney, P; Yu, C; Storb, R
      Nonmyeloablative transplants: Preclinical and clinical results

      SEMINARS IN ONCOLOGY
    44. Storb, R; McSweeney, PA; Sandmaier, BM; Nash, RA; Georges, G; Maloney, DG; Molina, A; Chauncey, T; Yu, C; Zaucha, JM; Blume, KG; Shizuru, J; Niederwieser, D
      Allogeneic hematopoietic stem cell transplantation: From the nuclear age into the twenty-first century

      TRANSPLANTATION PROCEEDINGS
    45. Hagglund, HG; McSweeney, PA; Mathioudakis, G; Bruno, B; Georges, GE; Gass, MJ; Moore, P; Sale, GE; Storb, R; Nash, RA
      Ex vivo expansion of canine dendritic cells from CD34(+) bone marrow progenitor cells

      TRANSPLANTATION
    46. Yu, C; Linsley, P; Seidel, K; Sale, G; Deeg, HJ; Nash, RA; Storb, R
      Cytotoxic T lymphocyte antigen 4-immmunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model

      TRANSPLANTATION
    47. Little, MT; Storb, R
      The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain

      JOURNAL OF CLINICAL INVESTIGATION
    48. Mosca, JD; Hendricks, JK; Buyaner, D; Davis-Sproul, J; Chuang, LC; Majumdar, MK; Chopra, R; Barry, F; Murphy, M; Thiede, MA; Junker, U; Rigg, RJ; Forestell, SP; Bohnlein, E; Storb, R; Sandmaier, BM
      Mesenchymal stem cells as vehicles for gene delivery

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    49. Zang, DY; Deeg, HJ; Gooley, T; Anderson, JE; Anasetti, C; Sanders, J; Myerson, D; Storb, R; Appelbaum, F
      Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    50. Nash, RA; Antin, JH; Karanes, C; Fay, JW; Avalos, BR; Yeager, AM; Przepiorka, D; Davies, S; Petersen, FB; Bartels, P; Buell, D; Fitzsimmons, W; Anasetti, C; Storb, R; Ratanatharathorn, V
      Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

      BLOOD
    51. Mielcarek, M; Leisenring, W; Torok-Storb, B; Storb, R
      Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect

      BLOOD
    52. Mathioudakis, G; Storb, R; McSweeney, PA; Torok-Storb, B; Lansdorp, PM; Brummendorf, TH; Gass, MJ; Bryant, EM; Storek, J; Flowers, MED; Gooley, T; Nash, RA
      Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients

      BLOOD
    53. Koc, S; Leisenring, W; Flowers, MED; Anasetti, C; Deeg, HJ; Nash, RA; Sanders, JE; Witherspoon, RP; Appelbaum, FR; Storb, R; Martin, PJ
      Thalidomide for treatment of patients with chronic graft-versus-host disease

      BLOOD
    54. Walters, MC; Storb, R; Patience, M; Leisenring, W; Taylor, T; Sanders, JE; Buchanan, GE; Rogers, ZR; Dinndorf, P; Davies, SC; Roberts, IAG; Dickerhoff, R; Yeager, AM; Hsu, L; Kurtzberg, J; Ohene-Frempong, K; Bunin, N; Bernaudin, F; Wong, WY; Scott, JP; Margolis, D; Vichinsky, E; Wall, DA; Wayne, AS; Pegelow, C; Redding-Lallinger, R; Wiley, J; Klemperer, M; Mentzer, WC; Smith, FO; Sullivan, KM
      Impact of bone marrow transplantation for symptomatic sickle cell disease:an interim report

      BLOOD
    55. Deeg, HJ; Shulman, HM; Anderson, JE; Bryant, EM; Gooley, TA; Slattery, JT; Anasetti, C; Fefer, A; Storb, R; Appelbaum, FR
      Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

      BLOOD
    56. Georges, GE; Storb, R; Thompson, JD; Yu, C; Gooley, T; Bruno, B; Nash, RA
      Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation

      BLOOD
    57. Wagner, JL; Storb, R; Storer, B; Mignot, E
      DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs

      TISSUE ANTIGENS
    58. Wagner, JL; Creer, SA; Storb, R
      Dog class I gene DLA-88 histocompatibility typing by PCR-SSCP and sequencing

      TISSUE ANTIGENS
    59. Kiem, HP; Storb, R
      Canine models for transplantation and gene therapy

      HEMATOPOIETIC STEM CELL TRANSPLANTION
    60. Kiem, HP; McSweeney, PA; Bruno, B; Goerner, M; Buron, G; Morris, J; Storb, R; Miller, AD
      Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector

      GENE THERAPY
    61. Storb, R; Yu, C; Sandmaier, B; McSweeney, P; Georges, G; Nash, R; Woolfrey, A
      Mixed hematopoietic chimerism after hematopoietic stem cell allografts

      TRANSPLANTATION PROCEEDINGS
    62. Yamaguchi, M; McSweeney, PA; Kimball, L; Gersuk, G; Hong, DS; Kwok, W; Storb, R; Beckham, C; Deeg, HJ
      Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis

      TRANSPLANTATION
    63. Bruno, B; Nash, RA; Wallace, PM; Gass, MJ; Thompson, J; Storb, R; McSweeney, PA
      CD34+selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation

      TRANSPLANTATION
    64. Barsoukov, AA; Moore, PF; Storb, R; Santos, EB; Sandmaier, BM
      The use of an anti-TCR alpha beta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation

      TRANSPLANTATION
    65. Wagner, JL; Burnett, RC; Storb, R
      Organization of the canine major histocompatibility complex: Current perspectives

      JOURNAL OF HEREDITY
    66. Mielcarek, M; Bryant, E; Loken, M; Torok-Storb, B; Storb, R
      Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    67. Martin, PJ; Rowley, SD; Anasetti, C; Chauncey, TR; Gooley, T; Petersdorf, EW; van Burik, J; Flowers, MED; Storb, R; Appelbaum, FR; Hansen, JA
      A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients

      BLOOD
    68. Goerner, M; Bruno, B; McSweeney, PA; Buron, G; Storb, R; Kiem, HP
      The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs

      BLOOD
    69. Storb, R; Yu, C; Zaucha, JM; Deeg, HJ; Georges, G; Kiem, HP; Nash, RA; McSweeney, PA; Wagner, JL
      Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig,and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant

      BLOOD
    70. Matthews, DC; Appelbaum, FR; Eary, JF; Fisher, DR; Durack, LD; Hui, TE; Martin, PJ; Mitchell, D; Press, OW; Storb, R; Bernstein, ID
      Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome

      BLOOD
    71. Storb, R; Yu, G; Barnett, T; Wagner, JL; Deeg, HJ; Nash, RA; Kiem, HP; McSweeney, P; Seidel, K; Georges, G; Zaucha, JM
      Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation

      BLOOD
    72. Clift, RA; Radich, J; Appelbaum, FR; Martin, P; Flowers, MED; Deeg, HJ; Storb, R; Thomas, ED
      Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia

      BLOOD
    73. STORB R; RAFF R; DEEG HJ; GRAHAM T; APPELBAUM FR; SCHUENING FG; SHULMAN H; SEIDEL K; LEISENRING W
      DOSE RATE-DEPENDENT SPARING OF THE GASTROINTESTINAL-TRACT BY FRACTIONATED TOTAL-BODY IRRADIATION IN DOGS GIVEN MARROW AUTOGRAFTS

      International journal of radiation oncology, biology, physics
    74. WAGNER JL; FLOWERS MED; LONGTON G; STORB R; SCHUBERT M; SULLIVAN KM
      THE DEVELOPMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE - AN ANALYSIS OFSCREENING STUDIES AND THE IMPACT OF CORTICOSTEROID USE AT 100 DAYS AFTER TRANSPLANTATION

      Bone marrow transplantation
    75. STORB R
      EXPERIMENTAL AND CLINICAL USE OF ALLOGENEIC BLOOD STEM-CELL TRANSPLANTS

      Bone marrow transplantation
    76. MARTIN P; NASH R; SANDERS J; LEISENRING W; ANASETTI C; DEEG HJ; STORB R; APPELBAUM F
      REPRODUCIBILITY IN RETROSPECTIVE GRADING OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION

      Bone marrow transplantation
    77. GEORGES GE; STORB R; BRUNVAND RW; KIEM HP; MOORE PF; MALIK P; ENNIST D; NASH RA
      CANINE T-CELLS TRANSDUCED WITH A HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE - A MODEL TO STUDY EFFECTS ON ENGRAFTMENT AND CONTROL OF GRAFT-VERSUS-HOST DISEASE

      Transplantation
    78. MARTIN PJ; SCHOCH G; GOOLEY T; ANASETTI C; DEEG HJ; NASH R; SANDERS J; STORB R; APPELBAUM F
      METHODS FOR ASSESSMENT OF GRAFT-VERSUS-HOST DISEASE

      Blood
    79. STUCKI A; LEISENRING W; SANDMAIER BM; SANDERS J; ANASETTI C; STORB R
      DECREASED REJECTION AND IMPROVED SURVIVAL OF FIRST AND 2ND MARROW TRANSPLANTS FOR SEVERE APLASTIC-ANEMIA (A 26-YEAR RETROSPECTIVE ANALYSIS)

      Blood
    80. RATANATHARATHORN V; NASH RA; PRZEPIORKA D; DEVINE SM; KLEIN JL; WEISDORF D; FAY JW; NADEMANEE A; ANTIN JH; CHRISTIANSEN NP; VANDERJAGT R; HERZIG RH; LITZOW MR; WOLFF SN; LONGO WL; PETERSEN FB; KARANES C; AVALOS B; STORB R; BUELL DN; MAHER RM; FITZSIMMONS WE; WINGARD JR
      PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION

      Blood
    81. CLIFT RA; BUCKNER CD; APPELBAUM FR; SULLIVAN KM; STORB R; THOMAS ED
      LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF 2 IRRADIATION REGIMENS FOR PATIENTS RECEIVING ALLOGENEIC MARROW TRANSPLANTS DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA

      Blood
    82. MORTON AJ; GOOLEY T; HANSEN JA; APPELBAUM FR; BRUEMMER B; BJERKE JW; CLIFT R; MARTIN PJ; PETERSDORF EW; SANDERS JE; STORB R; SULLIVAN KM; WOOLFREY A; ANASETTI C
      ASSOCIATION BETWEEN PRETRANSPLANT INTERFERON-ALPHA AND OUTCOME AFTER UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

      Blood
    83. SANDMAIER BM; STORB R; BENNETT KL; APPELBAUM FR; SANTOS EB
      EPITOPE SPECIFICITY OF CD44 FOR MONOCLONAL ANTIBODY-DEPENDENT FACILITATION OF MARROW ENGRAFTMENT IN A CANINE MODEL

      Blood
    84. YU C; SEIDEL K; NASH RA; DEEG HJ; SANDMAIER BM; BARSOUKOV A; SANTOS E; STORB R
      SYNERGISM BETWEEN MYCOPHENOLATE MOFETIL AND CYCLOSPORINE IN PREVENTING GRAFT-VERSUS-HOST DISEASE AMONG LETHALLY IRRADIATED DOGS GIVEN DLA-NONIDENTICAL UNRELATED MARROW GRAFTS

      Blood
    85. MCSWEENEY PA; ROULEAU KA; WALLACE PM; BRUNO B; ANDREWS RG; KRIZANACBENGEZ L; SANDMAIER BM; STORB R; WAYNER E; NASH RA
      CHARACTERIZATION OF MONOCLONAL-ANTIBODIES THAT RECOGNIZE CANINE CD34

      Blood
    86. WAGNER JL; WORKS JD; STORB R
      DLA-DRB1 AND DLA-DQB1 HISTOCOMPATIBILITY TYPING BY PCR-SSCP AND SEQUENCING

      Tissue antigens
    87. WAGNER JL; HAYESLATTIN B; WORKS JD; STORB R
      MOLECULAR ANALYSIS AND POLYMORPHISM OF THE DLA-DQB GENES

      Tissue antigens
    88. GRAUMANN MB; DEROSE SA; OSTRANDER EA; STORB R
      POLYMORPHISM ANALYSIS OF 4 CANINE MHC-CLASS-I GENES

      Tissue antigens
    89. DEEG HJ; LEISENRING W; STORB R; NIMS J; FLOWERS MED; WITHERSPOON RP; SANDERS J; SULLIVAN KM
      LONG-TERM OUTCOME AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA

      Blood
    90. STOREK J; MENDELMAN PM; WITHERSPOON RP; MCGREGOR BA; STORB R
      IGG RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE APPEARSSIMILAR TO IGG RESPONSE TO POLYSACCHARIDE IN BONE-MARROW TRANSPLANT RECIPIENTS AND HEALTHY-ADULTS

      Clinical infectious diseases
    91. GLIMM H; KIEM HP; DAROVSKY B; STORB R; WOLF J; DIEHL V; MERTELSMANN R; VONKALLE C
      EFFICIENT GENE-TRANSFER IN PRIMITIVE CD34(+) CD38(LO) HUMAN BONE-MARROW CELLS RESELECTED AFTER LONG-TERM EXPOSURE TO GALV-PSEUDOTYPED RETROVIRAL VECTOR/

      Human gene therapy
    92. DEEG HJ; SEIDEL K; HONG DS; YU C; HUSS R; SCHUENING FG; EWEL CH; STORB R
      IN-VIVO RADIOPROTECTIVE EFFECT OF ACSDKP ON CANINE MYELOPOIESIS

      Annals of hematology
    93. DEMIRER T; BUCKNER CD; STORER B; LILLEBY K; ROWLEY S; CLIFT R; APPELBAUM FR; STORB R; BENSINGER WI
      EFFECT OF DIFFERENT CHEMOTHERAPY REGIMENS ON PERIPHERAL-BLOOD STEM-CELL COLLECTIONS IN PATIENTS WITH BREAST-CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR

      Journal of clinical oncology
    94. STOREK J; GOOLEY T; WITHERSPOON RP; SULLIVAN KM; STORB R
      INFECTIOUS MORBIDITY IN LONG-TERM SURVIVORS OF ALLOGENEIC MARROW TRANSPLANTATION IS ASSOCIATED WITH LOW CD4 T-CELL COUNTS

      American journal of hematology
    95. NELSON JL; TORREZ R; LOUIE FM; CHOE OS; STORB R; SULLIVAN KM
      PREEXISTING AUTOIMMUNE-DISEASE IN PATIENTS WITH LONG-TERM SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Journal of rheumatology
    96. STORB R
      HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN NONMALIGNANT DISEASES

      Journal of rheumatology
    97. NASH RA; MCSWEENEY PA; STORB R; NELSON JL; GAUTHIER J; FURST DE; SULLIVAN KM
      DEVELOPMENT OF A PROTOCOL FOR ALLOGENEIC MARROW TRANSPLANTATION FOR SEVERE SYSTEMIC-SCLEROSIS - PARADIGM FOR AUTOIMMUNE-DISEASE

      Journal of rheumatology
    98. MCSWEENEY PA; NASH RA; STORB R; FURST DE; GAUTHIER J; SULLIVAN KM
      AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR AUTOIMMUNE-DISEASES - ISSUESIN PROTOCOL DEVELOPMENT

      Journal of rheumatology
    99. SCHUENING FG; VONKALLE C; KIEM HP; APPELBAUM FR; DEEG HJ; PEPE M; GOOLEY T; GRAHAM TC; HACKMAN RC; STORB R
      EFFECT OF RECOMBINANT CANINE STEM-CELL FACTOR, A C-KIT LIGAND, ON HEMATOPOIETIC RECOVERY AFTER DLA-IDENTICAL LITTERMATE MARROW TRANSPLANTS IN DOGS

      Experimental hematology
    100. THURSTON GM; HAYDEN DL; BURROWS P; CLARK JI; TARET VG; KANDEL J; COUROGEN M; PEETERMANS JA; BOWEN MS; MILLER D; SULLIVAN KM; STORB R; STERN H; BENEDEK GB
      QUASI-ELASTIC LIGHT-SCATTERING STUDY OF THE LIVING HUMAN LENS AS A FUNCTION OF AGE

      Current eye research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 22:19:09